Cytokine response in patients with chronic infections caused by Staphylococcus aureus strains and diversification of their Agr system classes by A. Szkaradkiewicz et al.
ARTICLE
Cytokine response in patients with chronic infections caused
by Staphylococcus aureus strains and diversification
of their Agr system classes
A. Szkaradkiewicz & T. M. Karpiński & A. Zeidler &
A. K. Szkaradkiewicz & H. Masiuk & S. Giedrys-Kalemba
Received: 15 March 2012 /Accepted: 20 April 2012 /Published online: 26 May 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract This study aimed to describe the levels of circulat-
ing cytokine levels produced by Th lymphocytes (IFN-γ, IL-
4, IL-10, IL-17A), as well as the levels of cytokines produced
by monocytes/macrophages (TNF-α, IL-1β, IL-12), in
patients with chronic infections caused by Staphylococcus
aureus strains, particularly in the context of the diversification
of their Agr system classes. The studies were conducted on
adult patients, including 50 patients with chronic suppurative
dermatitis, 40 patients with chronic infections of the upper
respiratory tract and 25 healthy individuals (control group).
Blood serum cytokine levels were measured by enzyme-
linked immunosorbent assay (ELISA). S. aureuswas detected
in cultures of suppurative dermal exudates or of pharyngeal
smears. Classes of Agr systems in the S. aureus strains were
identified using polymerase chain reaction (PCR). In both
groups of patients, on average, levels of IFN-γ were doubled,
while levels of IL-17A were increased by 2.5-fold, which,
however, was not accompanied by increased levels of TNF-
α or IL-12. The data indicate that the development of S.
aureus infection among the studied patients was linked to an
impoverished cytokine response of monocytes/macrophages,
while that induced by the pathogen lymphocytes Th17/Th1
may be responsible for promotion of the chronic inflammatory
response. In parallel, no quantitative or qualitative differences
were disclosed between cytokine responses manifested by
subgroups of patients infected with S. aureus strains belong-
ing to class IV Agr, as compared to patients infected with
strains of classes I to III Agr. Nevertheless, in the patients,
strains belonging to class IVAgr prevailed, which points to the
preferential relationship between the class and the pathoge-
nicity of S. aureus.
Introduction
The propensity of humans to develop community-acquired
chronic infections with Staphylococcus aureus is well known
and is most frequently manifested by chronic suppurative
dermatitis or chronic infection in the upper respiratory tract.
Therapy of such conditions with antibiotics used to be inef-
fective and linked to a persisting infection with S. aureus
[1–4]. The role of immune reactions in the pathogenesis of
chronic S. aureus infections still remains unclear. In the im-
mune reaction, a very significant role is played by the cytokine
response of lymphocytes Th and of monocytes/macrophages
[5]. In turn, the pathogenicity of S. aureus is determined by the
production of several virulence factors, in the pathogen
remaining under the control of the global regulatory system
Agr (accessory gene regulator), encoded by the agr locus
[6–9]. Polymorphism of the agr locus allows to distinguish
four major different classes of Agr system, referred to as Agr-
I, Agr-II, Agr-III and Agr-IV. In parallel, their relationship is
examined in relation to the type of human disease caused by S.
aureus [10–12]. Considering the above, this study aimed to
evaluate the circulating cytokine levels, mainly those pro-
duced by subpopulations of lymphocytes T helper (Th):
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interferon (IFN)-γ, interleukin (IL)-4, IL-10 and IL-17A, as
well as of cytokines, mainly those produced by monocytes/
macrophages: tumour necrosis factor (TNF)-α, IL-1β and IL-
12, in patients with chronic staphylococcal infection in the
context of diversification between Agr classes among the
clinically isolated strains of S. aureus.
Materials and methods
Patients
The studies were performed in the Department of Med-
ical Microbiology, University of Medical Sciences in
Poznań and in the Department of Microbiology and
Immunology, Pomeranian Medical University in Szcze-
cin, Poland, over a period of two years (2010–2011).
All the research protocols were reviewed and approved
by the Ethics Committee at the University of Medical
Sciences in Poznań, Poland.
A total of 90 adult patients with chronic suppurative
dermatitis or chronic infection in the upper respiratory
tract induced by S. aureus (referred by dermatologists
and otolaryngologists) were recruited into the study.
Additionally, 25 healthy individuals without bacteriolog-
ical evidence of S. aureus infection served as a control
group. Taking into account clinical data and the results
of bacteriological tests, three study groups were distin-
guished. Group 1 included 50 patients (28 men, 22
women, age range: 18–52, mean: 35.3±9.2 years) with
exacerbation or a relapse of chronic suppurative derma-
titis, manifested at least within the previous 6 months
before inclusion into the study by chronic folliculitis or
a relapsing furunculosis with isolation from the suppu-
rative dermal exudate of S. aureus. Group 2 included 40
patients (18 men, 22 women, age range: 18–52, mean:
36.4±9.4 years) with exacerbation of chronic infection
in the upper respiratory tract, manifested at least within
the previous 6 months before inclusion to the studies of
chronic rhinopharyngitis or chronic pharyngitis, in the
throat smears of whom the presence of S. aureus was
disclosed. Group 3 (control) included 25 patients (11
men, 14 women, age range: 18–50, mean: 33.6±
9.4 years) in whom bacteriological examination of nasal
and pharyngeal smears failed to demonstrate the pres-
ence of S. aureus. Moreover, dental examinations of
patients failed to find any potential infection foci in
the oral cavity. Within the previous 2 weeks, none of
the patients in the mentioned groups were administered
with antibiotics/chemotherapeutic agents locally or sys-
temically. The material for studies involved nasal and
pharyngeal smears, exudate from suppurative skin
lesions and samples of peripheral blood.
S. aureus detection
The bacteria were isolated on sheep blood agar within 20–
24 h at a temperature of 37 °C in aerobic conditions. The
developed colonies were subsequently identified as
coagulase-positive staphylococci using conventional techni-
ques (colony morphology, evaluation of haemolysis, stain-
ing according to Gram, production of coagulase, catalase,
ability to decompose mannitol in Chapman medium). Final
identification of S. aureus was conducted using the auto-
mated system ATB with the application of ID 32 Staph
strips (bioMérieux). In the examined materials, the presence
of no other pathogens was disclosed.
Purification of DNA
DNA was isolated from the obtained isolates of S. aureus
clinical strains. At first, the samples were digested with
lysostaphin (10 μl of 1 mg/ml solution) and incubating them
for 10 min at a temperature of 37 °C. Subsequently, 20 μl of
proteinase K was added to each sample and, following
mixing, the samples were incubated for 20 min at a temper-
ature of 37 °C.
For the isolation of DNA, Sherlock AX (A&A Biotech-
nology, Gdynia, Poland) kits were used. The isolation of
DNA was conducted as recommended by the manufacturer.
The purified DNA was stored at −20 °C until further anal-
yses were performed.
Detection of Agr classes
The Agr classes were determined by two duplexes of poly-
merase chain reaction (PCR) according to the method of
Shopsin et al. [11]. Since the PCR product sizes of Agr classes
I and III and classes II and IV were similar, two duplex PCR
reactions were performed. The reverse primers I (product size:
440 bp) and IV (product size: 588 bp) were used in the first
reaction, and primers II (product size: 572 bp) and III (product
size: 406 bp) were used in the second reaction.
PCR was performed in the Mastercycler gradient thermal
cycler (Eppendorf). Aliquots of amplified samples (10 μL)
were analysed by electrophoresis on a 1 % agarose gel and
stained with ethidium bromide.
Determination of cytokines
Cytokines were estimated in patient sera using an immu-
noenzymatic technique (enzyme-linked immunosorbent as-
say, ELISA). The tests took advantage of the following kits:
for IFN-γ: Human IFN-γ High Sensitivity ELISA kit (eBio-
science), manifesting a minimum detection dose (MDD) of
0.06 pg/ml; for IL-4: Quantikine HS Human IL-4 Immuno-
assay kit (R&D Systems), manifesting an MDD of 0.11 pg/
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ml; for IL-10: Quantikine HS Human IL-10 Immunoassay
kit (R&D Systems), manifesting an MDD of 0.5 pg/ml; for
IL-17A: Platinum Human IL-17 ELISA kit (eBioscience),
manifesting an MDD of 0.5 pg/ml; for TNF-α: Quantikine
HS Human TNF-α/TNFSF1A Immunoassay kit (R&D Sys-
tems), manifesting an MDD of 0.106 pg/ml; for IL-1β:
Quantikine HS Human IL-1β/IL-1F2 Immunoassay kit
(R&D Systems), manifesting an MDD of 0.057 pg/ml; for
IL-12: Human IL-12p70 High Sensitivity ELISA kit (eBio-
science), manifesting an MDD of 0.1 pg/ml.
The tests were performed as recommended by the man-
ufacturers. Values of absorbance, depending on the estimat-
ed cytokine, were read at a wavelength of A0450 nm or
490 nm using Reader 250 (bioMérieux). The results were
obtained from standard curves.
Data analysis
In the comparative analysis of cytokine levels in the studied
groups, the non-parametric test of Kruskal–Wallis with
Dunn’s test was employed.
In the analysis of Agr class systems in the examined strains
of S. aureus, Student’s t-test for fractions was employed,
indicating a difference between two structural indices.
In every test, hypotheses were verified at the significance
level of p00.05.
Results
Levels of IFN-γ, IL-4, IL-10 and IL-17A cytokines, produced
by lymphocytes Th, detected in the sera of patient groups with
S. aureus infections, manifesting by chronic suppurative der-
matitis (group 1), chronic inflammation of the upper respira-
tory tract (group 2) and in healthy individuals are listed in
Table 1. In group 1, the mean levels of IFN-γ and IL-17A
amounted to 0.98±0.55 pg/ml and 4.93±1.54 pg/ml, respec-
tively. In group 2, the mean levels of IFN-γ and IL-17A
amounted to 0.87±0.51 pg/ml and 4.87±1.57 pg/ml, respec-
tively. The levels manifested no significant differences be-
tween patient groups 1 and 2, but they were significantly
higher than those in group 3 (control). In turn, levels of IL-4
and IL-10 did not differ from those in the control group.
Levels of TNF-α, IL-1β and IL-12, the cytokines pro-
duced by monocytes/macrophages, detected in the sera of
patients (groups 1 and 2) and in healthy individuals (group
3) are presented in Table 2. Levels of TNF-α and IL-12 in
both groups of the patients fitted the normal range. On the
other hand, the mean levels of IL-1β in groups 1 and 2
amounted to 0.54±0.25 pg/ml and 0.50±0.25 pg/ml, respec-
tively. They manifested no significant differences between
groups 1 and 2, but they were significantly higher than the
values in the control group.
The diversification of individual Agr classes among the S.
aureus strains isolated from the patients is presented in Table 3.
In groups 1 and 2, the proportion of S. aureus strains with Agr
IV phenotype amounted to 58 % and 65 %, respectively, and
such a phenotype was significantly more frequent than the
remaining phenotypes of Agr I–III. In parallel, no significant
difference in the diversification of Agr classes could be dem-
onstrated between groups 1 and 2 (p>0.05).
In the analysis of cytokine response profiles in the con-
text of the isolated strains of S. aureus in each of the patient
groups (group 1 and group 2), respective subgroups of 1a
and 2a were distinguished, linked to the isolated S. aureus
strains manifesting the phenotype of Agr I–III, and sub-
groups 1b and 2b, linked to S. aureus strains manifesting
Agr IV phenotype. Levels of IFN-γ, IL-4, IL-10 and IL-17A
detected in the sera of patients in the subgroups 1a, 1b, 2a
and 2b are presented in Table 4. The obtained levels of the
studied cytokines manifested no significant differences be-
tween subgroups 1a and 1b or between subgroups 2a and 2b
(p>0.05). Levels of TNF-α, IL-1β and IL-12, detected in
the sera of patients in subgroups 1a, 1b, 2a and 2b are
Table 1 Levels of cytokines produced by lymphocytes Th (IFN-γ, IL-
4, IL-10, IL-17A) in the sera of patients with chronic suppurative
dermatitis (group 1), with chronic inflammation in the upper respira-
tory tract (group 2) and in the control group (group 3)







IFN-γ 0.98±0.55* 0.87±0.51* 0.44±0.33
IL-4 0.29±0.14 0.28±0.14 0.24±0.12
IL-10 1.82±1.28 1.72±1.28 1.58±0.97
IL-17A 4.93±1.54* 4.87±1.57* 1.93±0.83
*Significant difference in cytokines levels between the patients and
healthy subjects
Table 2 Cytokines levels produced by monocytes/macrophages
(TNF-α, IL-1β, IL-12) in the sera of patients with chronic suppurative
dermatitis (group 1), with chronic inflammation in the upper respira-
tory tract (group 2) and in the control group (group 3)







TNF-α 0.77±0.39 0.74±0.3 0.61±0.36
IL-1β 0.54±0.25* 0.50±0.25* 0.26±0.14
IL-12 0.45±0.35 0.42±0.33 0.38±0.31
*Significant difference in cytokines levels between the patients and
healthy subjects
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presented in Table 5. Levels of the examined cytokines
manifested no significant differences between subgroups
1a and 1b or between subgroups 2a and 2b (p>0.05).
Discussion
This study analysed the levels of the circulating cytokines
secreted by subpopulations of Th lymphocytes and mono-
cytes/macrophages in patients with S. aureus chronic infec-
tions, and diversified classes of Agr systems among the
isolated clinical strains of S. aureus. IFN-γ, mainly produced
by activated Th1 lymphocytes, provides an optimal help for
cellular immunity, including pronounced stimulation of
monocytes/macrophages [13, 14]. On the other hand, IL-4
and IL-10, produced mainly by activated Th2 lymphocytes,
provide optimal help for humoral immune response, while
they suppress the reactions controlled by Th1 cells and, in
parallel, they diminish pro-inflammatory functions of mono-
cytes/macrophages [13, 15]. IL-17, in turn, produced mainly
by activated Th17 lymphocytes, represents a pro-
inflammatory cytokine, playing a significant role in the induc-
tion of local or systemic immune reactions, by firstly recruit-
ing neutrophils against infectious agents [16, 17]. Classical
pro-inflammatory cytokines, TNF-α, IL-1β and IL-12, pro-
duced mainly by activated monocytes/macrophages, demon-
strate a broad immunostimulatory activity and, in parallel,
they cooperate with IL-17 in the induction of inflammatory
host reactions [18].
In this study, elevated levels of IFN-γ and IL-17A were
documented, but IL-4 and IL-10 levels were within the
normal ranges in the sera of patients with S. aureus infec-
tions, manifested by chronic suppurative dermatitis or
chronic inflammation in the upper respiratory tract. The
results point to a continuous response of Th1/Th17 lympho-
cytes, accompanied by a failed induction of Th2 cells in the
course staphylococcal chronic infection. In part, the conclu-
sion corroborates the earlier studies of Breuer et al. [19] and,
recently, those of Niebuhr et al. [20], who showed that α-
toxin, the 33-kDa cytolysin secreted by S. aureus, induced
the release of IFN-γ and IL-17 in human CD4+ T cells.
Moreover, staphylococcal peptidoglycan (PGN), with medi-
ation of dendritic cells (DCs), was noted to induce Th1/
Th17 response [21]. In addition, in the most common in-
flammatory human skin diseases, atopic dermatitis [22] and
psoriasis [23], an increase was noted in circulating Th1 and
Th17 cells. Apart from the distinct lines of Th1 and Th17
lymphocytes, also the mixed Th17/Th1 cell type is distin-
guished, which combines the pro-inflammatory potential of
Th17 and Th1 cells, being characterised by the production
of both IFN-γ and IL-17 [24]. These Th17/Th1 cells man-
ifest a stable coexpression of transcription factors T-bet and
RORγt, most probably originating from Th17 lymphocytes,
and account for a rare population of circulating cells, repre-
senting only 0.05–0.11 % of CD4+ T cells in human healthy
blood [25, 26]. In the context of the data, the increased
levels of IFN-γ and IL-17A detected by us in the sera of
patients may reflect a preferential induction and accumula-
tion of Th17/Th1 cells in the foci of dermatitis or upper
respiratory mucositis induced by S. aureus infection. Secre-
tory activity of the cells is probably involved in the devel-
opment of chronic inflammatory processes, linked to S.
aureus infection. This potential has been demonstrated by
in vitro studies of Boniface et al. [27], showing that, in
contrast to human Th1 or Th17 lymphocytes, Th17/Th1
cells manifest a greater propensity to induce inflammation
on epithelial cells. On the other hand, Cho et al. [28]
Table 3 Diversification of Agr system classes among S. aureus iso-
lates obtained from the examined patients of groups 1 and 2





between groups 1 and 2
I 12 (24 %) 8 (20 %) p00.6513
II 5 (10 %) 3 (7.5 %) p00.6798
III 4 (8 %) 3 (7.5 %) p00.8588
IV 29 (58 %)* 26 (65 %)* p00.5003
*Difference in the frequency of manifestation, as compared to Agr
classes I, II and III, at the level of p<0.001
Table 4 Cytokine levels pro-
duced by lymphocytes Th (IFN-
γ, IL-4, IL-10, IL-17A) in the
sera of patients in subgroups 1a
and 2a, linked to S. aureus iso-
lates manifesting Agr I–III phe-
notypes, and subgroups 1b and
2b, linked to S. aureus strains
manifesting Agr IV phenotype
Studied
cytokine
Mean values in pg/ml ± SD
Group 1, n050 Group 2, n040








IFN-γ 1.01±0.59 0.96±0.52 0.81±0.49 0.91±0.52
IL-4 0.38±0.16 0.32±0.14 0.31±0.14 0.33±0.15
IL-10 1.84±1.17 1.81±1.37 1.79±1.27 1.68±1.31
IL-17A 5.1±1.66 4.81±1.47 4.98±1.75 4.82±1.5
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demonstrated, using a mouse model, that IL-17, priming
neutrophil recruitment, is ultimately required for host defence
against S. aureus skin infections. The 2.5-fold increase in
circulating IL-17A detected by us in patients is apparently
insufficient for the induction of an adequate response against
S. aureus infection but, together with the released IFN-γ, it
may promote the development of a chronic inflammatory
process. In our study, we have demonstrated a doubled in-
crease in levels of circulating IFN-γ, which, however, was not
accompanied by increased levels of circulating TNF-α and IL-
12. In turn, the augmented level of circulating IL-1β detected
by us might have resulted from secretion of the cytokine by
IFN-γ stimulated cells of vascular endothelium [29]. Thus, the
demonstrated increased levels of IFN-γ are insufficient for an
effective induction of secretory function in monocytes/macro-
phages. In parallel, studies of Minegishi et al. [30] docu-
mented an immunological role of anti-staphylococcal
factors, including neutrophil-recruiting chemokines and anti-
microbial peptides, the secretion of which by human kerati-
nocytes and bronchial epithelial cells is deeply dependent on
the synergistic action of IL-17 and the combination of other
pro-inflammatory cytokines (TNF-α + IL-1β + IFN-γ). In
that context, it seems probable that the development of infec-
tion with S. aureus in the studied patients was linked to an
insufficient stimulation of epithelial cell secretory function in
the skin and upper respiratory tract due to impoverished
cytokine response of monocytes/macrophages. In parallel,
the preferentially pathogen-induced lymphocytes Th17/Th1
may be responsible for the promotion of chronic dermatitis
or chronic respiratory tract infection. Quite possibly, S. aureus
strains with deficient production of delta-toxin are responsible
for the preferential induction, as it has seemed to be indicated
by recent studies of Gagnaire et al. [31]. In turn, Zielinski et al.
[32] have found that, due to a continuous stimulation by a
pathogen, Th17 cells may acquire the ability to produce IL-10.
In parallel, the above-quoted authors have shown that the
phenomenon is inhibited by IL-1β. The data correspond to
the increased levels of IL-1β demonstrated by us in this study.
Among the isolated strains of S. aureus, originating either
from patients with suppurative infections or from patients
with upper respiratory tract inflammation, we have demon-
strated a significant dominance of class IV Agr, while
diversification of the remaining Agr classes demonstrated no
significant differences. The dominance of class IVAgr among
strains isolated from Polish patients, mainly patients with
suppurative infections, has been described previously [33].
Moreover, strains with class IV Agr were found to be rare
among healthy carriers of S. aureus [33, 34]. A relationship
was also described between strains of S. aureus belonging to
class IV Agr and the production of epidermolytic toxins
(exfoliatins, ETs) and the phylogenetic group AF1, in contrast
to AF2, which corresponded to strains of class I and II Agr,
and AF3, which corresponded to strains of class III Agr [10,
35]. In this study, however, in none of the patients could
generalised or localised forms of staphylococcal scalded skin
syndrome (SSSS) be diagnosed, induced by ETs [36]. Thus,
the clinical data indicate that the strains isolated from S.
aureus patients produced no ETs. Moreover, the sera of stud-
ied patients demonstrated no extremely high levels of IFN-γ,
IL-17A or IL-1β and concentrations of TNF-α remained
within the normal range. It is already well recognised that
the toxins released by S. aureus, including enterotoxins, toxic
shock syndrome toxin-1 and ETs, exert activity of superanti-
gens on the host immune system [36, 37]. Such an activity
results in extremely high levels of circulating various cyto-
kines, including TNF-α [37, 38].
Upon analysis of the studied profile of cytokine response,
we have demonstrated no qualitative or quantitative differ-
ences between subgroups of patients linked to infections
with S. aureus strains belonging to class IVAgr and patients
infected with strains belonging to the remaining classes I–III
Agr. The data allow to suggest that the antigenic profile of
virulence factors released by S. aureus does not depend on
the Agr class of the pathogen. The suggestion corroborates
the earlier studies of Jarraud et al. [10], pointing to an
absence of a direct role of the Agr class in the type of human
disease induced by S. aureus. Nevertheless, in contrast to
healthy carriers of S. aureus, strains isolated from patients
are dominated by those belonging to class IV Agr. Thus, it
seems possible that this Agr phenotype is particularly linked
to the activation of virulence factors, which preconditions its
preferential relationship with the pathogenicity of S. aureus.
Thus, our results demonstrate that patients with S. aureus
infections, manifested by chronic suppurative dermatitis or
Table 5 Cytokines levels pro-
duced by monocytes/macro-
phages (TNF-α, IL-1β, IL-12)
in the sera of patients in sub-
groups 1a and 2a, linked to S.
aureus isolates manifesting Agr
I–III phenotypes, and subgroups
1b and 2b, linked to S. aureus




Mean values in pg/ml ± SD
Group 1, n050 Group 2, n040








TNF-α 0.68±0.36 0.84±0.4 0.82±0.36 0.7±0.26
IL-1β 0.48±0.26 0.58±0.24 0.47±0.26 0.52±0.25
IL-12 0.42±0.36 0.48±0.35 0.37±0.34 0.45±0.33
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chronic inflammation of the upper respiratory tract, develop
a Th17/Th1 cytokine response, not accompanied by a suffi-
cient pro-inflammatory response of monocytes/macro-
phages. Therefore, it is possible that lymphocytes Th17/
Th1 are responsible for the promotion of a chronic inflam-
matory process induced by S. aureus. In parallel, it was
demonstrated that cytokine response does not differ between
subgroups of patients infected with S. aureus strains belong-
ing to class IVAgr and those infected with strains belonging
to the remaining classes I–III Agr. In patients, the strains of
class IV Agr prevailed, which points to a preferential rela-
tionship between the class and pathogenicity of S. aureus.
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